TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
EUDA Health Holdings ( (EUDA) ) just unveiled an announcement.
On November 7, 2025, EUDA Health Holdings Limited finalized an agreement with an institutional investor to convert the remaining $162,500 balance of a previously issued convertible promissory note into 81,250 ordinary shares. This conversion marks the completion of a financial arrangement initially set in motion on August 1, 2025, and reflects the company’s strategic financial management to enhance its equity base. The decision not to issue further notes under the existing purchase agreement suggests a shift in the company’s financial strategy, potentially impacting its market positioning and stakeholder relations.
The most recent analyst rating on (EUDA) stock is a Buy with a $6.00 price target. To see the full list of analyst forecasts on EUDA Health Holdings stock, see the EUDA Stock Forecast page.
More about EUDA Health Holdings
EUDA Health Holdings Limited operates within the healthcare industry, focusing on providing innovative health solutions. The company is involved in the issuance and management of convertible promissory notes, which are financial instruments that can be converted into company shares, indicating a focus on financial strategies to support its operations.
Average Trading Volume: 117,403
Technical Sentiment Signal: Sell
Current Market Cap: $110M
Learn more about EUDA stock on TipRanks’ Stock Analysis page.